Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (2)

2022

  1. YES1 Is a Druggable Oncogenic Target in SCLC

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403

2021

  1. Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

    European Journal of Cancer, Vol. 151, pp. 211-220